Preliminary construction and validation of a prognostic prediction model for cervical cancer based on tumor mechanics-related genes - Scorecard - MDSpire

Preliminary construction and validation of a prognostic prediction model for cervical cancer based on tumor mechanics-related genes

  • By

  • Lu Zhang

  • Haonan Fu

  • Yali Feng

  • Jianxin Tian

  • Xue Gao

  • Yuhong Shang

  • June 3, 2026

  • 0 min

Share

Clinical Scorecard: Development and validation of a prognostic model for cervical cancer utilizing genes associated with tumor mechanics

At a Glance

CategoryDetail
Condition
Key MechanismsTumor mechanics-related genes (TMRGs) and tumor stiffness, emphasizing their prognostic significance.
Target Population
Care Setting

Key Highlights

  • highlight_3

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • S
      • p
      • e
      • c
      • i
      • f
      • y
      • m
      • e
      • t
      • h
      • o
      • d
      • s
      • a
      • n
      • d
      • f
      • r
      • e
      • q
      • u
      • e
      • n
      • c
      • y
      • f
      • o
      • r
      • m
      • o
      • n
      • i
      • t
      • o
      • r
      • i
      • n
      • g
      • M
      • M
      • P
      • 1
      • e
      • x
      • p
      • r
      • e
      • s
      • s
      • i
      • o
      • n
      • l
      • e
      • v
      • e
      • l
      • s
      • .

      Risks

        Patient & Prescribing Data

        Individuals diagnosed with cervical cancer

        High-risk patients may require more aggressive treatment strategies based on prognostic model outcomes.

        Clinical Best Practices

        • best_practice_4

        Related Resources & Content

        Original Source(s)

        Preliminary construction and validation of a prognostic prediction model for cervical cancer based on tumor mechanics-related genes

        • by Lu Zhang, Haonan Fu, Yali Feng, Jianxin Tian, Xue Gao, Yuhong Shang

        • June 3, 2026

        Related Content

        Prognostic inflammatory–immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter study

        Emerging insights into the role of BDH1 in the pathogenesis of human cancer

        Successful conversion therapy for presumed granulocyte colony-stimulating factor–producing hepatocellular carcinoma: a case report